Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

ANNOUNCEMENT

PROPOSED AMENDMENTS TO THE EQUITY INCENTIVE SCHEME

AND

GRANTING THE INCENTIVE SHARES TO CONNECTED PERSONS

Reference is made to the Company's announcement dated May 29, 2018 and the circular dated May 30, 2018 (the "Circular") in relation to the adoption of the Equity Incentive Scheme by the Company and authorization to the Board to deal with, in its absolute discretion, matters relating to the Equity Incentive Scheme of the Company. Unless otherwise defined in this announcement, capitalized terms used in this announcement shall have the same meaning as those defined in the Circular.

The Board hereby announces that on April 16, 2021, the Board considered and approved (among others) (a) proposed amendments to the Equity Incentive Scheme; and (b) the proposal to grant the Incentive Shares to connected persons.

PROPOSED AMENDMENTS TO THE EQUITY INCENTIVE SCHEME

In order to further implement the Equity Incentive Scheme and fulfill the incentive purposes thereof, without prejudice to the interests of the Company and the Shareholders as a whole, the Board, in consideration of the actual operating situation of the Company and market practice, intends to amend the functional basis and scope for determining the Participants (the "Proposed Amendments"). Following the amendments to the Equity Incentive Scheme (the "Amended Equity Incentive Scheme"), the scope of the Participants shall be extended to include all of the Directors, Supervisors and the general manager of the Company. The details of the Proposed Amendments are as follows:

1

Original

Amended

1.

Description of the Incentive Scheme

1.

Description of the Incentive Scheme

(3)

Basis for determining the Participants

(3)

Basis for determining the Participants

and the scope of the Participants

and the scope of the Participants

(a)

Basis for determining the Participants

(a)

Basis for determining the Participants

(ii)

Functional basis for determining the

(ii)

Functional basis for determining the

Participants

Participants

The Participants of the Incentive Scheme shall

The Participants of the Incentive Scheme shall

include senior management of the Group,

include the Directors, Supervisors,senior

core technical (business) personnel, and other

management of the Group (including the

persons who, in the opinion of the Board, shall

general manager), core technical (business)

be incentivized.

personnel, and other persons who, in the

opinion of the Board, shall be incentivized.

(b)

Scope of the Participants

(b)

Scope of the Participants

The Participants of the Incentive Scheme under

The Participants of the Incentive Scheme under

the first grant comprise a total of 179 persons,

the first grant comprise a total of 179 persons,

including:

including:

(i)

Senior management of the Group;

(i)

Senior management of the Group;

(ii)

Core technical (business) personnel of the

(ii)

Core technical (business) personnel of the

Group; and

Group; and

(iii)

Other persons who, in the opinion of the

(iii)

Other persons who, in the opinion of the

Board, shall be incentivized.

Board, shall be incentivized.

The abovementioned Participants of the

The abovementioned Participants of the

Incentive Scheme shall exclude all of the

Incentive Scheme shall exclude all of the

Directors, all of the Supervisors and the general

Directors, all of the Supervisors and the general

manager of the Company. All Participants shall

manager of the Company. All Participants shall

be employed in the Group and have signed

be employed in the Group and have signed

labor contracts or employment contracts with

labor contracts or employment contracts with

the Group during the appraisal period of the

the Group during the appraisal period of the

Incentive Scheme.

Incentive Scheme.

Participants under the reserved grant shall be Participants under the reserved grant shall determined with reference to the criteria under be determined with reference to the criteriathe first grant, and the Board shall determine under the first grantinclude the Directors,the Participants and the amount of equity to be Supervisors, senior management of thegranted within 36 months upon consideration Group (including the general manager), coreand approval of the Incentive Scheme at a technical (business) personnel, and other

general meeting.persons who, in the opinion of the Board, shall be incentivized, and the Board shall determine the Participants and the amount of equity to be granted within 36 months upon consideration and approval of the Incentive Scheme at a general meeting.

2

For the details of the Equity Incentive Scheme, please refer to the Circular. Except for the above amendments, the other contents of the Equity Incentive Scheme remain unchanged. The Board believes that the Proposed Amendments shall not have a material impact on the financial conditions and operating results of the Company.

The Company will propose a special resolution at the annual general meeting for the year 2020 of the Company (the "Annual General Meeting") to approve (among others) the Proposed Amendments.

GRANTING THE INCENTIVE SHARES TO CONNECTED PERSONS

Pursuant to the Amended Equity Incentive Scheme and combining with the relevant content of the Proposed Amendments, the Board intends to grant reserved Incentive Shares to connected persons who meet the granting conditions (the "Proposed Grantees") (the "Proposed Grant"), the details of which are as follows:

  1. Grant Price: RMB10.47 per share
  2. The number of grantees: 10 persons
  3. The number of Incentive Shares to be granted: 455,588 Shares
  4. The source of Incentive Shares: Non-tradable and Non-listed Domestic Shares issued to the Employees' Shareholding Platform by the Company (the Proposed Grant of Incentive Shares will not lead to issuance of new Shares by the Company)

3

5. The list of Participants:

The amount

The number

As a percentage

of Incentive

of Incentive

As a percentage

of the total

Shares to be

Shares to be

of the Incentive

Incentive Shares

granted

granted

Shares proposed

under the Equity

Name

Title

(RMB)

(Shares)

to grant

Incentive Scheme

Ms. WANG

Director and General

Lianyue

Manager

2,600,000

248,328

54.51%

10.09%

Ms. WANG

Director and Chief

Hongyue

Financial Officer

1,000,000

95,511

20.96%

3.88%

Mr. SUN Fangjun

Chairman of the

Supervisory Committee

150,000

14,327

3.14%

0.58%

Mr. XU Yi

Vice General Manager

300,000

28,653

6.29%

1.16%

Mr. XIE Tiefan

Staff Representative

Supervisor

50,000

4,776

1.05%

0.19%

Ms. WANG Biyu

Manager of Auditing and

Supervision

Department

50,000

4,776

1.05%

0.19%

Ms. XU Qunyan

Manager of Finance

Department

50,000

4,776

1.05%

0.19%

Mr. GUAN Weilu

Assistant to President

200,000

19,102

4.19%

0.78%

Mr. SUN Hongbo

Attending Doctor

320,000

30,563

6.71%

1.24%

Ms. ZHANG

Director of Social

Linghui

Work Department

50,000

4,776

1.05%

0.19%

Total

4,770,000

455,588

100%

18.52%

Note: The number of Incentive Shares to be granted to the Proposed Grantees is determined based on "the amount of Incentive Shares to be granted" set out in the above table. If there is any difference between the total number and the sum of the figures preceding them in the above table, it is caused by rounding adjustments.

The funds used by the Proposed Grantees for subscribing for restricted Shares, exercising the Share options and paying individual income tax shall be derived from their own funds. In respect of subscribing for Incentive Shares, the Company undertakes not to provide loans to the Proposed Grantees, nor any other financial aids, such as providing guarantee for their loans.

Upon completion of the Proposed Grant, the public float of the Company will still comply with the requirements under the Listing Rules.

REASONS FOR AND BENEFITS OF THE PROPOSED GRANT

The Board believes that the Proposed Grant will help further establish and optimize the Company's long-term incentive mechanism, attract and retain talent, fully mobilize the enthusiasm of the Company's Directors, Supervisors, senior management, middle management, and core technical (business) personnel and other persons who, in the opinion of the Board, shall be incentivized, effectively combine the interests of Shareholders, the interests of the Company and the personal interests of the core team, so as to ensure all parties will pay attention to the long-term development of the Company and enhance its operating efficiency.

The Board believes that the terms and conditions of the Proposed Grant are fair and reasonable, on normal commercial terms, and in the interests of the Company and Shareholders as a whole, and the Proposed Grant shall not have a material impact on the financial conditions and operating results of the Company.

4

IMPLICATIONS OF THE LISTING RULES

As (1) Ms. WANG Lianyue is a Director and general manager of the Company; (2) Ms. WANG Hongyue is the younger sister of Ms. WANG Lianyue and a Director of the Company; (3) Mr. SUN Fangjun and Mr. XIE Tiefan are Supervisors of the Company; (4) Mr. XU Yi is the spouse of Ms. WANG Hongyue; (5) Ms. WANG Biyu is the niece of Ms. WANG Lianyue and Ms. WANG Hongyue; (6) Ms. XU Qunyan is the younger sister of Mr. XU Yi; (7) Mr. GUAN Weilu is the younger brother of Mr. GUAN Weili (the Chairman and an executive Director of the Company);

  1. Mr. SUN Hongbo is the nephew of Ms. WANG Lianyue and Ms. WANG Hongyue; and (9) Ms. ZHANG Linghui is the sister-in-law of Mr. GUAN Weili, according to Chapter 14A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ("Listing Rules"), the Participants are connected persons of the Company. Therefore, the Proposed Grant constitutes a non-exempt connected transaction of the Company and is subject to the reporting, announcement and independent shareholders' approval requirements under Chapter 14A of the Listing Rules. The Proposed Grant is subject to the approval of independent Shareholders of the Company. The Company will submit the relevant resolution and seek independent Shareholders' approval for the Proposed Grant at the Annual General Meeting.

Mr. GUAN Weili, Ms. WANG Lianyue and Ms. WANG Hongyue have abstained from voting due to their material interests in the Proposed Grant in the relevant Board resolution. Save as disclosed above, none of the Directors own any material interests in the Proposed Grant and no Director is required to abstain from voting on the relevant Board resolution.

The Company will establish an independent board committee comprising all independent non-executive Directors to provide recommendations to independent Shareholders as to the Proposed Grant. The Company has appointed Gram Capital Limited as its independent financial advisor to provide recommendations to independent board committee and independent Shareholders as to the abovementioned matters.

A circular containing, among others, (i) details of the Proposed Amendments; (ii) details of the Proposed Grant; (iii) letter from the independent board committee; (iv) letter from the independent financial adviser; and (v) notice of the Annual General Meeting is expected to be dispatched to Shareholders on or before May 14, 2021. Since additional time is required to prepare the information to be included in the circular, the circular is expected to be despatched to Shareholders more than 15 business days after the date of this announcement.

By Order of the Board

Wenzhou Kangning Hospital Co., Ltd.

GUAN Weili

Chairman

Zhejiang, the PRC

April 16, 2021

As of the date of this announcement, the executive Directors of the Company are Mr. GUAN Weili, Ms. WANG Lianyue and Ms. WANG Hongyue; the non-executive Directors of the Company are Mr. YANG Yang and Mr. LIN Lijun; and the independent non-executive Directors of the Company are Mr. ZHAO Xudong, Ms. ZHONG Wentang and Mr. LIU Ning.

5

Attachments

  • Original document
  • Permalink

Disclaimer

Wenzhou Kangning Hospital Co. Ltd. published this content on 16 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 April 2021 08:41:04 UTC.